Article
APOE: a potential marker of disease progression in ALS.
Neurology - 9 Apr 2002
Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat P-F, Bruckert E, Meininger V
Abstract excerpt
Although documented in AD, the role of APOE remains unclear in ALS. APOE phenotype and plasma levels were measured in 403 patients with ALS and were correlated with clinical parameters and survival time. No correlations were observed between the APOE phenotype and these variables. In contrast, APOE plasma levels were correlated with both rate of deterioration and survival time and appeared to be an important risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.